Buprenorphine Hcl/Naloxone Hcl
Brand name: Buprenorphine-Naloxone
Rank #125 of 500 drugs by total cost
$135.8M
Total Cost
696,008
Total Claims
$135.8M
Total Cost
12,026
Prescribers
$195
Cost per Claim
81,827
Beneficiaries
699,571
30-Day Fills
$11K
Avg Cost/Provider
58
Avg Claims/Provider
About Buprenorphine Hcl/Naloxone Hcl
Buprenorphine Hcl/Naloxone Hcl (sold as Buprenorphine-Naloxone) was prescribed 696,008 times by 12,026 Medicare Part D providers in 2023, costing the program $135.8M. At $195 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 122 | Alpha-1-Proteinase Inhibitor (Prolastin C) | $137.9M | 12,352 |
| 123 | Dasatinib (Sprycel) | $136.8M | 10,389 |
| 124 | Oxycodone Hcl/Acetaminophen (Oxycodone-Acetaminophen) | $136.4M | 3,487,099 |
| 125 | Buprenorphine Hcl/Naloxone Hcl (Buprenorphine-Naloxone) | $135.8M | 696,008 |
| 126 | Cenegermin-Bkbj (Oxervate) | $133.5M | 3,601 |
| 127 | Teriflunomide (Aubagio) | $131.9M | 18,010 |
| 128 | Umeclidinium Bromide (Incruse Ellipta) | $131.6M | 290,677 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology